Jörg Stockhaus
Fondatore presso conoGenetix biosciences GmbH
Posizioni attive di Jörg Stockhaus
Società | Posizione | Inizio | Fine |
---|---|---|---|
conoGenetix biosciences GmbH
conoGenetix biosciences GmbH Pharmaceuticals: MajorHealth Technology conoGenetix biosciences GmbH develops peptide-based drugs and new ion channel selective drugs. It runs programs targeting severe autoimmune disorders like multiple sclerosis, rheumatoid arthritis, and vasculitis. The firm development pipeline encompasses peptide design, electrophysiology testing, biophysical parameters and synthesis, proliferation assays, and animal testing and toxicology. The company was founded by Andreas Klostermann, Mira Klostermann and Jörg Stockhaus in March 2002 and is headquartered in Planegg, Germany. | Direttore Tecnico/Scientifico/R&S | 01/03/2002 | - |
Fondatore | 01/03/2002 | - | |
The Rockefeller University | Corporate Officer/Principal | - | - |
Storia della carriera di Jörg Stockhaus
Precedenti posizioni note di Jörg Stockhaus
Società | Posizione | Inizio | Fine |
---|---|---|---|
Aventis Cropscience | Corporate Officer/Principal | - | - |
Heinrich-Heine-Universität Düsseldorf | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
Germania | 3 |
Francia | 2 |
Stati Uniti | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Settori
Consumer Services | 3 |
Process Industries | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Aventis Cropscience | Process Industries |
conoGenetix biosciences GmbH
conoGenetix biosciences GmbH Pharmaceuticals: MajorHealth Technology conoGenetix biosciences GmbH develops peptide-based drugs and new ion channel selective drugs. It runs programs targeting severe autoimmune disorders like multiple sclerosis, rheumatoid arthritis, and vasculitis. The firm development pipeline encompasses peptide design, electrophysiology testing, biophysical parameters and synthesis, proliferation assays, and animal testing and toxicology. The company was founded by Andreas Klostermann, Mira Klostermann and Jörg Stockhaus in March 2002 and is headquartered in Planegg, Germany. | Health Technology |
- Borsa valori
- Insiders
- Jörg Stockhaus
- Esperienza